Showing results (21-30 of 120) with videos related to
Sort By:
Pageof 12
Cancer Research|October 18, 2002
Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma developmentMeryl E Lusher, Janet C Lindsey, Farida Latif, et al.Cancer Research|February 21, 2006
Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapseJane Carr, Emma Bell, Andrew D J Pearson, et al.Cancer Letters|July 26, 2003
The p53 pathway and its inactivation in neuroblastomaDeborah A Tweddle, Andrew D J Pearson, Michelle Haber, et al.Cancer Genetics and Cytogenetics|July 18, 2006
APC and CTNNB1 mutations are rare in sporadic ependymomasOlabisi E Onilude, Meryl E Lusher, Janet C Lindsey, et al.Pediatric Blood & Cancer|January 3, 2013
Long-term follow-up of children with high-risk neuroblastoma: the ENSG5 trial experienceLucas Moreno, Sucheta J Vaidya, C Ross Pinkerton, et al.Current Drug Targets|January 7, 2014
MDM2-p53 interaction in paediatric solid tumours: preclinical rationale, biomarkers and resistanceGiuseppe Barone, Deborah A Tweddle, Jason M Shohet, et al.Cancer Chemotherapy and Pharmacology|August 25, 2009
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patientsGareth J Veal, Michael Cole, Julie Errington, et al.Plos One|March 27, 2014
Intrinsic susceptibility MRI identifies tumors with ALKF1174L mutation in genetically-engineered murine models of high-risk neuroblastomaYann Jamin, Laura Glass, Albert Hallsworth, et al.Pediatric Blood & Cancer|April 5, 2025
A 2035 Clinical Research Vision and Roadmap for High-Risk NeuroblastomaLucas Moreno, Steven G Dubois, Nicholas Bird, et al.Cancer|January 13, 2004
Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behaviorTamás Tornóczky, Endre Kálmán, Pál G Kajtár, et al.Pageof 12